Clin2
NCT07875933Likely a fitNot yet recruiting

Triple therapy for H. pylori infection

H. Pylori Eradication Therapy

Treatments studied

This study tests a new combination of three medicines to treat H. pylori, a stomach bacteria that can cause ulcers. If you have H. pylori and have not been treated for it before, this trial might help you get rid of the infection.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 3
Enrollment
414 people
Ages
19 years to 75 years
Study type
Interventional

Who can take part

  • You are between 19 and 75 years old.
  • You have been confirmed to have H. pylori infection through a breath test or a stomach tissue test.
  • You have not had any prior treatment to eradicate H. pylori.
  • You do not have active bleeding in your stomach or a history of stomach surgery that affects acid production.
  • You do not have Zollinger-Ellison syndrome or other conditions causing too much stomach acid.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07115173Not yet recruiting· Phase 4
Triple therapy for h. pylori infection

This study tests a three-drug combination (called triple therapy) to get rid of H. pylori, a bacteria that can cause stomach problems like ulcers and inflammation. If you have H. pylori and one of the listed stomach conditions, this treatment might help clear the infection.

NCT07344506Recruiting· Phase 4
Cure H. pylori: New combination therapy for stomach infection

This trial tests a new combination of medications to treat H. pylori, a common stomach infection that can cause ulcers. It aims to find a more effective treatment with fewer side effects.

Karachi
NCT06200779Not yet recruiting· Phase 4
Personalized versus standard treatment for H. pylori infection

This study is testing whether giving H. pylori treatment based on the specific bacteria found in your stomach works better than the standard one-size-fits-all approach. If you are already getting an endoscopy with a biopsy, this trial could help find the most effective medication for your infection.

Porto, Porto District
NCT07606833Not yet recruiting· Phase 3
Combination therapy for helicobacter pylori infection

This trial tests a new medication combined with standard antibiotics and bismuth to treat helicobacter pylori, a bacteria that can cause stomach ulcers. It aims to see if this combination is safe and effective in clearing the infection.

Shenzhen, Guangdong
NCT06760065Not yet recruiting· Phase 3
New two-medicine approach for stubborn H. pylori infection

This study tests a simpler two-medicine treatment against a four-medicine approach for people whose first H. pylori treatment failed. It aims to see if the simpler option works just as well in clearing the infection.

NCT06349486Recruiting
Comparing new treatments for H. pylori infection

This trial compares three different medication combinations to see which works best for treating H. pylori infection. If you have H. pylori and haven't been treated yet, you may be able to join.

Kaohsiung City

Hear when a new H. Pylori Eradication Therapy trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.